Search Results for "HIV"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for HIV. Results 171 to 180 of 181 total matches.

Low-Dose Transdermal Estrogens

   
The Medical Letter on Drugs and Therapeutics • Aug 27, 2007  (Issue 1268)
Vaginosis Maraviroc (Selzentry) for HIV Lapatinib (Tykerb) for Breast Cancer Coming Soon in Treatment ...
Three low-dose transdermal estrogens were recently approved by the FDA for treatment of menopausal vasomotor symptoms. Elestrin and Divigel are transdermal estradiol gels and Evamist is an estradiol spray. Elestrin has been marketed in Europe since 1976.
Med Lett Drugs Ther. 2007 Aug 27;49(1268):71-2 |  Show IntroductionHide Introduction

Acute Reactions to Drugs of Abuse

   
The Medical Letter on Drugs and Therapeutics • Mar 04, 2002  (Issue 1125)
can cause sepsis or endocarditis, and the incidence of HIV infection is high among IV drug abusers ...
Acute toxic reactions to drugs of abuse continue to be important problems. Some patients may have mixed intoxications with complex combinations of signs and symptoms.
Med Lett Drugs Ther. 2002 Mar 4;44(1125):21-4 |  Show IntroductionHide Introduction

Transdermal Rotigotine (Neupro) for Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Aug 27, 2007  (Issue 1268)
Vaginosis Maraviroc (Selzentry) for HIV Lapatinib (Tykerb) for Breast Cancer Coming Soon in Treatment ...
Rotigotine (Neupro - Schwarz Pharma), a nonergot dopamine agonist in a transdermal patch formulation, was recently approved by the FDA for treatment of early Parkinson's disease (PD).
Med Lett Drugs Ther. 2007 Aug 27;49(1268):69-70 |  Show IntroductionHide Introduction

Treatment of Onychomycosis

   
The Medical Letter on Drugs and Therapeutics • Oct 18, 2021  (Issue 1635)
to have the disease.2 Risk factors include older age, diabetes, poor peripheral circulation, smoking, HIV infection ...
Onychomycosis is caused most commonly by Trichophyton rubrum or T. mentagrophytes. About 10% of all persons worldwide and 40% of those ≥60 years old are believed to have the disease. Risk factors include older age, diabetes, poor peripheral circulation, smoking, HIV infection, psoriasis, and immunosuppression. Left untreated, onychomycosis can cause nail plate destruction, ingrown nails, and (particularly in patients with diabetes) secondary infections. Guidelines on treatment of onychomycosis have been published.
Med Lett Drugs Ther. 2021 Oct 18;63(1635):164-8 |  Show IntroductionHide Introduction

Expanded Table: Some Drugs for Inflammatory Bowel Disease (online only)

   
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023  (Issue 1680)
with HIV and immunosuppression Hypersensitivity reactions Severe infections, including tuberculosis ...
View the Table: Some Drugs for Inflammatory Bowel Disease
Med Lett Drugs Ther. 2023 Jul 10;65(1680):e115-9   doi:10.58347/tml.2023.1680d |  Show IntroductionHide Introduction

Choice of Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2023  (Issue 1676)
. Only condoms can pre vent STIs, including HIV infection. Vaginal Gel ― A nonhormonal vaginal gel ...
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80   doi:10.58347/tml.2023.1676a |  Show IntroductionHide Introduction

Management of Opioid Withdrawal Symptoms

   
The Medical Letter on Drugs and Therapeutics • Aug 27, 2018  (Issue 1554)
treatment is associated with high rates of relapse, overdose death, and HIV and/or hepatitis C virus ...
Pharmacologic management of opioid withdrawal symptoms can reduce the intensity of drug craving and improve treatment retention in patients with opioid use disorder who will receive maintenance treatment. Withdrawal management without subsequent maintenance treatment is associated with high rates of relapse, overdose death, and HIV and/or hepatitis C virus infection. Several guidelines on management of opioid withdrawal are available. Maintenance treatment of opioid use disorder was reviewed in a previous issue.
Med Lett Drugs Ther. 2018 Aug 27;60(1554):137-42 |  Show IntroductionHide Introduction

Treatment of Common Respiratory Tract Infections

   
The Medical Letter on Drugs and Therapeutics • Apr 17, 2023  (Issue 1674)
, such as influenza, SARS-CoV-2, Epstein-Barr, rhinovirus, and HIV, and should not be treated with antibiotics ...
Most respiratory tract infections are caused by viruses. Bacterial respiratory tract infections are usually treated empirically with antibiotic therapy that targets the most probable causative pathogens. Recommended antibiotic regimens for outpatient treatment of some common respiratory tract infections are listed in Table 1 for adults and Table 2 for children.
Med Lett Drugs Ther. 2023 Apr 17;65(1674):57-62   doi:10.58347/tml.2023.1674a |  Show IntroductionHide Introduction

Drugs for Inflammatory Bowel Disease

   
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023  (Issue 1680)
case of PML has been reported with vedolizumab in a patient with HIV and prior and concomitant ...
Ulcerative colitis (UC) and Crohn's disease (CD), referred to collectively as inflammatory bowel disease (IBD), are chronic immune-mediated inflammatory conditions. Guidelines for treatment of UC and CD have been updated in recent years
Med Lett Drugs Ther. 2023 Jul 10;65(1680):105-12   doi:10.58347/tml.2023.1680a |  Show IntroductionHide Introduction

Drugs for Cardiac Arrhythmias

   
Treatment Guidelines from The Medical Letter • Jun 01, 2007  (Issue 58)
is not available generically. Coming Soon in Treatment Guidelines: Drugs for Non-HIV Viral Infections – July 2007 ...
The drugs of choice for treatment of common cardiac arrhythmias are listed in Tables 1 and 2. Some drugs are recommended for indications that have not been approved by the FDA.
Treat Guidel Med Lett. 2007 Jun;5(58):51-8 |  Show IntroductionHide Introduction